These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9611904)

  • 1. Fecal occult blood tests. A cost-effectiveness analysis.
    Gyrd-Hansen D
    Int J Technol Assess Health Care; 1998; 14(2):290-301. PubMed ID: 9611904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of new occult blood tests for detection of colorectal neoplasia.
    St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
    Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
    Castiglione G; Zappa M; Grazzini G; Mazzotta A; Biagini M; Salvadori P; Ciatto S
    Br J Cancer; 1996 Jul; 74(1):141-4. PubMed ID: 8679448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
    Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
    JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of fecal occult-blood tests for colorectal-cancer screening.
    Allison JE; Tekawa IS; Ransom LJ; Adrain AL
    N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia.
    Rozen P; Knaani J; Samuel Z
    Dig Dis Sci; 1997 Oct; 42(10):2064-71. PubMed ID: 9365136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: a cost-effectiveness analysis.
    van Rossum LG; van Rijn AF; Verbeek AL; van Oijen MG; Laheij RJ; Fockens P; Jansen JB; Adang EM; Dekker E
    Int J Cancer; 2011 Apr; 128(8):1908-17. PubMed ID: 20589677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for colorectal cancer: current status in Japan.
    Saito H
    Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S78-84. PubMed ID: 11052482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.
    Winawer SJ; Flehinger BJ; Schottenfeld D; Miller DG
    J Natl Cancer Inst; 1993 Aug; 85(16):1311-8. PubMed ID: 8340943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
    O'Leary BA; Olynyk JK; Neville AM; Platell CF
    J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The estimation of sensitivity and specificity in colorectal cancer screening methods.
    Walter SD; Frommer DJ; Cook RJ
    Cancer Detect Prev; 1991; 15(6):465-9. PubMed ID: 1782636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening: efficiency and effectiveness.
    Gyrd-Hansen D; Søgaard J; Kronborg O
    Health Econ; 1998 Feb; 7(1):9-20. PubMed ID: 9541080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of retesting subjects with a positive Hemoccult in screening for colorectal cancer.
    Kewenter J; Engarås B; Haglind E; Jensen J
    Br J Surg; 1990 Dec; 77(12):1349-51. PubMed ID: 2276015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians.
    Ransohoff DF; Lang CA
    Ann Intern Med; 1997 May; 126(10):811-22. PubMed ID: 9148658
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.